<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Geriatric health maintenance
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Geriatric health maintenance
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Geriatric health maintenance
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mitchell T Heflin, MD, MHS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth E Schmader, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 20, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The profile of aging in the United States has changed dramatically over the last century. The average life expectancy at birth has increased from 47 years in 1900 to nearly 79 years in 2014. By 2030, the percentage of the population over 65 years of age will exceed 20 percent, or over 70 million people [
         <a href="#rid1">
          1
         </a>
         ]. Worldwide, the number of adults over 60 years of age will top 2 billion by 2050 and will constitute over 20 percent of the world's population [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Definitions of health and wellbeing in late life have changed with the increase in life expectancy. Heart disease, cancer, and stroke have become the leading causes of death among older adults, while deaths due to infection have decreased. Adults surviving into late life suffer from high rates of chronic illness; 80 percent have at least one and 50 percent have at least two chronic conditions [
         <a href="#rid1">
          1
         </a>
         ]. There is a strong association between the presence of geriatric syndromes (cognitive impairment, falls, incontinence, vision or hearing impairment, low body mass index, dizziness) and dependency in activities of daily living [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Decline in function and loss of independence are not an inevitable consequence of aging. Given the high prevalence and impact of chronic health problems among older patients, evidence-based interventions to address these problems become increasingly important to maximize both the quantity and quality of life for older adults.
        </p>
        <p>
         This topic offers a brief discussion of office-based assessments to identify and address common problems that are amenable to prevention or amelioration in older adults. An overview of preventive medicine for the general population is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/97819.html" rel="external">
          "Overview of preventive care in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H104693352">
         <span class="h1">
          GOALS OF CARE FOR OLDER ADULTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physiologic and functional status vary greatly among older adults. This wide heterogeneity means that treatment decisions, both preventive and therapeutic, should be considered based on individual needs. Age alone should not be the sole determinant for many interventions, and all treatments should aim to preserve function and maximize quality of life.
        </p>
        <p>
         For decisions related to screening and other preventive interventions, the concept of lag time to benefit is relevant [
         <a href="#rid4">
          4
         </a>
         ]. If a screening intervention, such as screening for colorectal cancer with fecal occult blood testing, has a lag time of 10 years for a risk reduction of one death per 1000 persons screened, and an individual has a predicted life expectancy of five years, then such screening would not be likely to provide benefit for that individual. Studies suggest that many older patients in the United States, and women in particular, are over-screened for certain conditions and under-screened or undertreated (eg, immunizations and counseling) for others [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
         A proposed framework for primary care for older individuals that defines short-term, mid-range, and long-term goals may help providers more appropriately and effectively prioritize issues in this population [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         <strong>
          Short-term issues
         </strong>
         : Focus on immediate needs to maintain or restore current health status; may be the sole focus for patients at the end of life.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptom management
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Care coordination
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Personal safety
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evaluate the living situation
        </p>
        <p>
        </p>
        <p>
         <strong>
          Mid-range issues
         </strong>
         : Address needs over the subsequent one to five years.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preventive care
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disease management
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psychological issues
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coping strategies
        </p>
        <p>
        </p>
        <p>
         <strong>
          Long-term issues
         </strong>
         : For older adults who are currently healthy and high functioning.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Plans to be implemented at the time of eventual decline
        </p>
        <p>
        </p>
        <p>
         Approximations of life expectancy based on health and function can help providers, patients, and caregivers in prioritizing issues and making decisions. Evidence-based tools available online at
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Feprognosis.ucsf.edu%2F&amp;token=FEE6F0JlRVF1b9TeuaII9KQd7CLxTAQWAQ1djW%2FZYbXIC4LkjJFTXUWC0NEtoVA7&amp;TOPIC_ID=3017" target="_blank">
          eprognosis.ucsf.edu
         </a>
         can help generate estimates of survival for older adults with different conditions and in different settings.
        </p>
        <p>
         Providers are encouraged to consider the individual patient's health status, preferences, and priorities in management of the issues discussed below. This review serves as a guide for discussions and decisions regarding use of preventive services among older adults, and also provides descriptions and tools useful in performing the assessments contained in the Medicare Initial Preventive Physical Examination (IPPE). (See
         <a class="local">
          'Medicare and preventive visits'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H94568221">
         <span class="h1">
          OVERVIEW OF PREVENTION FOR OLDER ADULTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A comprehensive summary of recommendations for screening and prevention for specific conditions is presented in a table  (
         <a class="graphic graphic_table graphicRef75220" href="/z/d/graphic/75220.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H94568227">
         <span class="h2">
          Healthy lifestyle
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encouraging older adults to adopt a healthy lifestyle may lower their risk of developing disability. In one cohort of individuals aged 65 and older who were without disability at baseline and followed for 12 years, the risk of developing moderate to severe disability was greater for individuals who had only low or intermediate levels of physical activity (hazard ratio [HR] 1.72, 95% CI 1.48-2.00), ate less than one serving of fruit or vegetable daily (1.24, CI 1.10-1.41), or were current or recent smokers (HR 1.26, CI 1.05-1.50) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Physical activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exercise benefits people of all ages and may decrease all-cause morbidity and increase lifespan [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
         All older adults, including the very old, those with multiple morbidities, or those who are in chronic care facilities, can benefit from physical activity. Participation in any amount of physical activity will result in some health benefit. Specific benefits among older adults include reduction in falls and fall-related injuries, and maintenance of physical function [
         <a href="#rid11">
          11
         </a>
         ]. A description of the benefits of exercise and a full discussion of exercise recommendations for older adults are presented separately. (See
         <a class="medical medical_review" href="/z/d/html/2786.html" rel="external">
          "The benefits and risks of aerobic exercise"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16524.html" rel="external">
          "Physical activity and exercise in older adults"
         </a>
         .)
        </p>
        <p>
         The American Heart Association (AHA) and the American College of Sport Medicine (ACSM) provide recommendations for adults over age 65 years for various types of activity and guides for implementing such programs [
         <a href="#rid12">
          12
         </a>
         ]. Specific exercises fall into four categories: aerobic, muscle strengthening, flexibility, and balance.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For aerobic activity, guidelines suggest a minimum of 30 minutes of moderate-intensity exercise on five days each week, or a minimum of 20 minutes of vigorous-intensity activity on three days each week, or some combination of the two [
         <a href="#rid12">
          12
         </a>
         ]. Definitions for moderate and vigorous activity depend on the person's baseline conditioning.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exercises to maintain and increase muscle strength include weight training, weightbearing calisthenics, or resistance training.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence supporting flexibility activities is less rigorous, but most experts recommend 10 minutes of some static stretching of major muscle groups on days when aerobic or muscle strengthening exercise is performed, to maintain range of motion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Balance training exercises are recommended to improve stability and prevent falls and injuries related to falls. Static balance training involves learning to recover balance on a tilting balance platform. Dynamic balance training that does not require special equipment, such as tai chi, may be more readily available outside of a formal supervised setting [
         <a href="#rid13">
          13-15
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The AHA/ACSM guidelines emphasize a graduated or stepwise introduction of physical activity to improve safety and adherence. An individualized "activity plan" should recommend levels of physical activity and define how the individual will meet them. Developing an activity plan, particularly for older adults with chronic conditions, may warrant input from physical therapists/exercise physiologists or referral to specialty programs (eg, cardiac or pulmonary rehabilitation). Routine electrocardiogram (EKG) or cardiac exercise testing are not indicated for asymptomatic patients who are preparing to undergo an exercise program. The Medicare Initial Preventive Physical Examination (IPPE), however, does provide coverage for an initial 12-lead EKG and its interpretation as part of the introductory visit. (See
         <a class="local">
          'Medicare and preventive visits'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/16524.html" rel="external">
          "Physical activity and exercise in older adults", section on 'Benefits of physical activity in older adults'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1519.html" rel="external">
          "Screening for coronary heart disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Tobacco use
         </span>
         <span class="headingEndMark">
          —
         </span>
         Older adults should be questioned about smoking and counseled on how to quit smoking if they currently smoke. Rates of smoking and tobacco use are lower for adults over age 65 than for younger individuals [
         <a href="#rid16">
          16
         </a>
         ]. Nonetheless, the older generation has a long history of high rates of smoking and excess smoking-related mortality from lung cancer, cardiovascular disease, and chronic obstructive pulmonary disease [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         High-quality evidence demonstrates that smoking cessation significantly reduces the risk for coronary heart disease, various cancers, and chronic obstructive pulmonary disease [
         <a href="#rid18">
          18
         </a>
         ]. One study addressed smoking cessation in older community-dwelling adults and found that, within five years of stopping smoking, the relative risk for all-cause mortality fell below that for current smokers [
         <a href="#rid19">
          19
         </a>
         ]. A meta-analysis found that the mortality benefits of smoking cessation were demonstrable at all ages, including in subjects age 80 years and older [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16706.html" rel="external">
          "Benefits and consequences of smoking cessation", section on 'All-cause mortality'
         </a>
         .)
        </p>
        <p>
         Ongoing regular counseling for smoking cessation for all patients who use tobacco products is recommended by the United States Preventive Services Task Force (USPSTF). (See
         <a class="medical medical_review" href="/z/d/html/6920.html" rel="external">
          "Behavioral approaches to smoking cessation"
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9698" href="/z/d/drug information/9698.html" rel="external">
          Nicotine
         </a>
         replacement therapy, although not specifically studied in older individuals, has been shown to be effective as an adjunct for selected patients [
         <a href="#rid21">
          21
         </a>
         ]. Other options, including
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         and
         <a class="drug drug_general" data-topicid="10339" href="/z/d/drug information/10339.html" rel="external">
          varenicline
         </a>
         , may also be reasonable choices for older patients [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Alcohol
         </span>
         <span class="headingEndMark">
          —
         </span>
         The American Geriatrics Society guidelines suggest specific questioning regarding the frequency and quantity of alcohol use, followed by asking the CAGE questions (
         <strong>
          C
         </strong>
         ut down,
         <strong>
          A
         </strong>
         nnoyed,
         <strong>
          G
         </strong>
         uilty,
         <strong>
          E
         </strong>
         ye-opener) to identify patients with alcohol-related problems [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">
          "Screening for unhealthy use of alcohol and other drugs in primary care", section on 'CAGE questions'
         </a>
         .)
        </p>
        <p>
         Nearly 50 percent of adults over age 65 years consume alcohol. Among these, 14.5 percent drink more than the recommended weekly allowance (&gt;7 drinks per week) or drink in binges. When accounting for concurrent medical problems, a survey classified 53 percent of older drinkers as having harmful or hazardous patterns of alcohol consumption [
         <a href="#rid24">
          24
         </a>
         ]. Alcohol use in older adults is associated with increased risk of falls and may negatively impact function and cognition, as well as general health [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Risk factors for alcohol abuse among older adults include bereavement, depression, anxiety, pain, disability, and a prior history of alcohol use. A variety of screening tools are effective for identifying alcohol misuse in older patients [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">
          "Screening for unhealthy use of alcohol and other drugs in primary care", section on 'Special populations'
         </a>
         .)
        </p>
        <p>
         The National Institute on Alcohol Abuse and Alcoholism has developed an excellent clinician tool for helping patients who consume alcohol to excess [
         <a href="#rid26">
          26
         </a>
         ]. Clinician recommendations and advice may be as effective as more detailed behavioral counseling programs at reducing alcohol use [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Limited role for aspirin in primary prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         may have the potential to decrease the risk of incident cardiovascular disease and cancer in some patient populations, it also increases the risk of bleeding, particularly among older adults. The 2022 USPSTF statement recommends against initiating low-dose aspirin for primary prevention in adults 60 years or older [
         <a href="#rid27">
          27
         </a>
         ]. For older adults already taking aspirin and who have no history of cardiovascular events, clinicians and patients should consider stopping it, particularly in those over age 75. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/16291.html" rel="external">
          "Aspirin in the primary prevention of cardiovascular disease and cancer"
         </a>
         .)
        </p>
        <p>
         Proton pump inhibitor (PPI) use may reduce gastrointestinal bleeding in higher-risk patients [
         <a href="#rid28">
          28
         </a>
         ]. Guidelines from the American College of Cardiology/American College of Gastroenterology/AHA suggest that all patients who are over 60 years of age and who have one additional risk factor (corticosteroid use, dyspepsia, or gastroesophageal reflux disease symptoms) should use a PPI if they are maintained on chronic
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         therapy [
         <a href="#rid29">
          29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/35.html" rel="external">
          "NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Immunizations
         </span>
         <span class="headingEndMark">
          —
         </span>
         A summary of recommended immunizations for adults from the United States Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) is shown in a Table  (
         <a class="graphic graphic_figure graphicRef82634" href="/z/d/graphic/82634.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef62130" href="/z/d/graphic/62130.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3946323398">
         <span class="h3">
          COVID-19
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vaccines to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are highly effective in preventing serious illness and death. Older adults are at increased risk of morbidity and mortality, and we encourage all older adults to receive vaccination, as recommended by the CDC [
         <a href="#rid30">
          30
         </a>
         ]. The epidemiology and clinical characteristics of coronavirus disease 2019 (COVID-19), including the impact of older age, are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features"
         </a>
         .)
        </p>
        <p>
         Detailed information on the available vaccines is presented in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">
          "COVID-19: Vaccines"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Tetanus or pertussis with tetanus vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical tetanus, though rare in the United States, occurs predominantly in unvaccinated or under-immunized older adults. Patients older than 60 years account for approximately 60 percent of all cases of tetanus in the United States [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         The ACIP recommends booster doses of adult-type tetanus and diphtheria toxoid (Td or Tdap) every 10 years.
        </p>
        <p>
         Vaccination against pertussis is important for adults who have close contact with infants aged younger than one year (such as grandparents, child care providers, and health care providers) [
         <a href="#rid32">
          32
         </a>
         ]. The only available adult vaccine against pertussis is the Tdap vaccine. Tdap should be administered regardless of the interval since the last dose of Td.
        </p>
        <p>
         Studies of the Td vaccine have demonstrated the efficacy and cost-effectiveness of a single booster in producing sustained immunity to both tetanus and diphtheria among older patients (aged 50 to 70) who had received a primary booster series [
         <a href="#rid33">
          33-35
         </a>
         ]. The ACIP still recommends a booster every 10 years, while the American College of Physicians (ACP) and the ACOVE authors support a single Td booster in later life (age &gt;50 years) in patients who have completed the primary series and have not had a booster within the last 10 years. (See
         <a class="medical medical_review" href="/z/d/html/3897.html" rel="external">
          "Tetanus-diphtheria toxoid vaccination in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Influenza vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         More than 90 percent of influenza-related deaths occur among people age 60 and over [
         <a href="#rid36">
          36
         </a>
         ]. Older adults also experience significantly increased morbidity from the disease.
        </p>
        <p>
         Annual influenza immunization for all adults is recommended by the CDC [
         <a href="#rid37">
          37
         </a>
         ]. Efficacy, choice of vaccine formulation, and adverse effects are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults", section on 'Choice of vaccine formulation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Pneumococcal vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pneumococcal disease is a significant cause of morbidity and mortality in older adults. Both the incidence of pneumococcal disease and the mortality rate increase after age 50 and more sharply after age 65 [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         UpToDate recommendations for pneumococcal vaccination in immunocompetent older adults are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/7021.html" rel="external">
          "Pneumococcal vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7021.html" rel="external">
          "Pneumococcal vaccination in adults", section on 'Approach to healthy older adults and those with predisposing medical conditions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Herpes zoster vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vaccinations to prevent herpes zoster are recommended for most older adults and are now updated to include a the more effective recombinant, adjuvanted vaccine. Specifics of vaccine formulations for herpes zoster, including indications, contraindications, and administration, are described in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/8343.html" rel="external">
          "Vaccination for the prevention of shingles (herpes zoster)"
         </a>
         .)
        </p>
        <p>
         Herpes zoster or shingles, due to reactivation of latent varicella zoster virus, causes a painful localized rash. Sequelae, including postherpetic neuralgia, encephalitis, myelitis, and palsies of cranial and peripheral nerves, are more common in older patients. Herpes zoster affects approximately 30 percent of individuals over their lifetime, with a substantial increase in risk (8- to 10-fold) in late life [
         <a href="#rid39">
          39
         </a>
         ]. Vaccine to prevent herpes zoster should not be used for the treatment of zoster or postherpetic neuralgia.
        </p>
        <p class="headingAnchor" id="H1063067990">
         <span class="h3">
          Respiratory syncytial virus vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2023, the US Food and Drug Administration approved a recombinant respiratory syncytial virus (RSV) vaccine (adjuvanted) for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older [
         <a href="#rid40">
          40
         </a>
         ]. A subsequent nonadjuvanted
         <a class="drug drug_general" data-topicid="141638" href="/z/d/drug information/141638.html" rel="external">
          recombinant respiratory syncytial virus vaccine
         </a>
         (RSVPreF) was also FDA approved in 2023 [
         <a href="#rid41">
          41
         </a>
         ]. Recommendations on the use of these vaccines have been put forth by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F72%2Fwr%2Fmm7229a4.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLDUG08ZbGAJiu0qbyu%2F2zoJlTydmg4OmgcKsXRQw2%2FV%2Fh950D6Ese%2FtAxoIPC8S%2FXg%3D%3D&amp;TOPIC_ID=3017" target="_blank">
          CDC
         </a>
         . Instead of a standard recommendation for routine use of these vaccines in older adults (like influenza or pneumococcal vaccines), the CDC recommended shared-decision-making. There was insufficient evidence for prevention of RSV-associated lower respiratory tract disease, hospitalization, or death by RSV vaccines in persons 75 years and older, persons who are frail, or persons who reside in long-term care facilities in the phase III clinical trials. These vaccines are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/142052.html" rel="external">
          "Respiratory syncytial virus infection in adults", section on 'Vaccination'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Screening asymptomatic older adults for selected cancers has the potential to allow more effective treatment through early detection. However, both screening tests and disease treatment have been less rigorously evaluated in older adults, leading to more uncertainty about the benefit of screening among older patients compared with younger individuals [
         <a href="#rid42">
          42,43
         </a>
         ]. Additionally, comorbid illness and frailty alter the risk-benefit ratio for screening in this group [
         <a href="#rid44">
          44
         </a>
         ]. A modeling study estimated harms and benefits in individuals with varying degrees of comorbidities related to regular screening starting at age 50 with mammography, prostate-specific antigen testing, and fecal immunochemical testing [
         <a href="#rid45">
          45
         </a>
         ]. The harms and benefits of screening for individuals age 76 with no comorbid conditions were equivalent to those age 74 with mild comorbidity, age 72 with moderate comorbidity, and age 66 with severe comorbidity.
        </p>
        <p>
         The decision to offer cancer screening to the older patient presents a clinical challenge. Clinicians should assess the benefits and risks of screening for older adults on an individual basis, considering the patient's estimated remaining life expectancy, and help patients make decisions based on personal values and preferences [
         <a href="#rid4">
          4,42,46,47
         </a>
         ].
        </p>
        <p>
         Primary care providers and patients report uncertainty and discomfort with the idea of discussing stopping cancer screening, particularly mammography. Provider scripts and strategies about stopping cancer screening in patients over 75 have been developed, with the goal of increasing provider ability to engage patients in an informed shared-decision-making process [
         <a href="#rid48">
          48
         </a>
         ]. These scripts provide specific language to concisely and clearly explain key issues including: guideline-based recommendations for stopping screening, the delay in benefit of up to 10 years, the problems of false positives and overdiagnosis, and how to engage patients in discussions ahead of screening about the risks and benefits of possible cancer treatments.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Prostate cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         The USPSTF updated its recommendations in 2018 [
         <a href="#rid49">
          49
         </a>
         ] to recommend individual discussion of the risks and benefits of prostate cancer screening and suggest that men between the ages of 50 to 69 years are most likely to benefit from screening. The decision to screen for prostate cancer should be based on individual discussions, involving patient preference for specific health outcomes and risks and benefits of screening. Black men, those known or likely to carry
         <em>
          BRCA1 o
         </em>
         r
         <em>
          BRCA2
         </em>
         genetic mutations, and those with a positive family history of prostate cancer should be informed of their higher lifetime risk. When a decision is made to screen, UpToDate suggests that screening stop when the patient's life expectancy is less than 10 years, or if the patient decides against further screening. (See
         <a class="medical medical_review" href="/z/d/html/7567.html" rel="external">
          "Screening for prostate cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2954742">
         <span class="h3">
          Colorectal cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Screening for colorectal cancer (CRC) can reduce cancer-specific mortality. Available CRC screening tests, their effectiveness and safety, and the frequency of testing recommended for adults who are at average risk for CRC are described in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7565.html" rel="external">
          "Screening for colorectal cancer: Strategies in patients at average risk"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7576.html" rel="external">
          "Tests for screening for colorectal cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2954749">
         <span class="h3">
          Breast cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Decisions about screening for breast cancer, especially in older women, should involve discussion of patient values and preferences and the potential benefits and harms of screening. Data from randomized trials of screening mammography demonstrated an approximate 19 to 30 percent reduction in breast cancer mortality among screened versus unscreened women, but these data do not reflect the improvement in outcome with current breast cancer treatment, and enrolled women only up to age 74 [
         <a href="#rid50">
          50-52
         </a>
         ]. Data from modelling studies of screening in older women suggest a mortality benefit for screening when the life expectancy is 10 years or more [
         <a href="#rid53">
          53
         </a>
         ]. A decision aid describing the risks and benefits of mammography screening for women aged 75 and older is available to help these women with decision-making around mammography screening [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">
          "Screening for breast cancer: Strategies and recommendations"
         </a>
         .)
        </p>
        <p>
         For women at average risk who opt to undergo mammography screening for breast cancer, screening biennially will detect nearly as many cancers as annual screening and reduces the risk of false-positive readings [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         The American Geriatrics Society has identified breast cancer screening as one of its targets for the "Choosing Wisely" campaign and recommends that breast cancer screening should not be undertaken in women with a life expectancy less than 10 years [
         <a href="#rid56">
          56
         </a>
         ]. Screening in women with shorter life expectancy would expose them to potential immediate harm with little chance of benefit.
        </p>
        <p class="headingAnchor" id="H36226287">
         <span class="h3">
          Cervical cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cervical cancer is no more aggressive in older women than younger women, and high-grade lesions are rare among older women who have been previously screened. Nonetheless, a substantial number of cervical cancers occur in older women, many of whom have had inadequate screening [
         <a href="#rid57">
          57-61
         </a>
         ]. In the United States, Medicare began providing reimbursement for Pap smear screening in 1990, motivated by findings that up to 40 percent of older adult women had never had a Pap smear [
         <a href="#rid62">
          62-65
         </a>
         ].
        </p>
        <p>
         Most major guidelines recommend stopping cervical cancer screening at age 65 for women who have had adequate recent screening and are not at increased risk for cervical cancer. Adequate screening is defined as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two consecutive negative primary human papillomavirus (HPV) tests within the past 10 years, with the most recent test within the previous five years; or
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two consecutive negative co-tests (Pap and HPV testing) within the past 10 years, with the most recent test within the previous five years; or
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Three consecutive negative Pap tests within the past 10 years, with the most recent test within the previous three years
        </p>
        <p>
        </p>
        <p>
         However, women who have a new sexual partner or are current or previous smokers generally should continue to be screened if their life expectancy is &gt;10 years. Women who have had a total hysterectomy with removal of the cervix for indications unrelated to cervical cancer should not undergo screening for cervical cancer. (See
         <a class="medical medical_review" href="/z/d/html/7575.html" rel="external">
          "Screening for cervical cancer in resource-rich settings", section on 'Age &gt;65 years'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7575.html" rel="external">
          "Screening for cervical cancer in resource-rich settings", section on 'Prior benign hysterectomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H94568809">
         <span class="h3">
          Lung cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Annual screening by low-dose chest CT scan has been found to reduce mortality in high-risk populations [
         <a href="#rid66">
          66
         </a>
         ]. Considering these findings, the 2021 USPSTF recommendations call for annual low-dose chest CT scan screening for high-risk individuals ages 50 to 80 years. Persons at increased risk are defined as those with at least a 20 pack-year smoking history, and either current smokers or former smokers having quit within the past 15 years. Screening is to be discontinued when a person has not smoked for 15 years or if life expectancy is limited. Multiple other organizations also support lung cancer screening for high-risk older adults  (
         <a class="graphic graphic_table graphicRef64078" href="/z/d/graphic/64078.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/7566.html" rel="external">
          "Screening for lung cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H94569241">
         <span class="h2">
          Cardiovascular screening
         </span>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Blood pressure screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypertension is highly prevalent among older adults (60 to 80 percent) and remains the leading risk factor for ischemic heart disease and stroke [
         <a href="#rid67">
          67
         </a>
         ]. In this age group, the USPSTF recommends measuring blood pressure annually to screen for hypertension [
         <a href="#rid68">
          68
         </a>
         ]. More frequent measurement may be indicated, depending on the patient's risk factors. This is described separately. (See
         <a class="medical medical_review" href="/z/d/html/3852.html" rel="external">
          "Overview of hypertension in adults", section on 'Detection'
         </a>
         .)
        </p>
        <p>
         While blood pressure lowering in hypertensive patients is associated with decreased mortality in many instances, aggressive treatment of hypertension in older adults may have adverse effects. Goal blood pressure and management of hypertension in the older adults are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">
          "Goal blood pressure in adults with hypertension"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3863.html" rel="external">
          "Treatment of hypertension in older adults, particularly isolated systolic hypertension"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Lipid screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of CHD attributable to lipids is similar across age ranges [
         <a href="#rid69">
          69
         </a>
         ]. Older adults have a higher overall annual risk of CHD and stand to benefit from lipid reduction if life expectancy warrants [
         <a href="#rid70">
          70
         </a>
         ]. As such, there is no particular age above which initial screening for lipid abnormalities should not be performed. However, in patients who have had more than one prior normal lipid profile, we suggest stopping screening at age 65. (See
         <a class="medical medical_review" href="/z/d/html/4553.html" rel="external">
          "Screening for lipid disorders in adults", section on 'Stopping screening'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4549.html" rel="external">
          "Low-density lipoprotein cholesterol-lowering therapy in the primary prevention of cardiovascular disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112841.html" rel="external">
          "Management of low density lipoprotein cholesterol (LDL-C) in the secondary prevention of cardiovascular disease"
         </a>
         .)
        </p>
        <p>
         The USPSTF has found good evidence that lipid measurement can identify asymptomatic people at increased risk of CHD, and good evidence that lipid-lowering drug therapy decreases the incidence of CHD in people with abnormal lipids and causes few major harms [
         <a href="#rid21">
          21
         </a>
         ]. The USPSTF concludes that the benefits of screening for and treating lipid disorders in older people outweigh harms, but notes that data are limited regarding primary prevention of CHD in older populations. There are no prospective randomized trials of lipid therapy that have included persons 80 years or older at baseline enrollment [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Lipid-lowering therapy clearly benefits older adults at high risk of coronary events. The benefit of primary prevention for low-risk older adults remains unclear. For those with an overall risk of CHD exceeding 10 percent over 10 years, screening and treatment appear to be substantiated [
         <a href="#rid69">
          69
         </a>
         ]. However, the decision to initiate lipid-lowering therapy in older adults, and particularly those 80 years and older, should be individualized based on comorbidities and recognition of problems that may arise from polypharmacy in this population. (See
         <a class="medical medical_review" href="/z/d/html/4553.html" rel="external">
          "Screening for lipid disorders in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3013.html" rel="external">
          "Drug prescribing for older adults", section on 'Polypharmacy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H94569305">
         <span class="h3">
          Abdominal aortic aneurysm
         </span>
         <span class="headingEndMark">
          —
         </span>
         Screening for abdominal aortic aneurysm (AAA) with a one-time abdominal ultrasound examination has been shown to decrease aneurysm-related deaths and all-cause mortality in men [
         <a href="#rid72">
          72,73
         </a>
         ]. Because the prevalence of AAA is lower in women, screening has not been shown to be effective in women [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         We, along with the USPSTF and the AHA, recommend one-time screening for AAA with abdominal ultrasonography in men ages 65 to 75 who have ever smoked. We also suggest one-time screening with abdominal ultrasonography in men ages 65 to 75 who have a first-degree relative who required AAA repair or died from AAA rupture. We offer screening to women who have a strong family history of either AAA repair or death due to AAA rupture, basing the decision to screen on their values and preferences. Screening is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7569.html" rel="external">
          "Screening for abdominal aortic aneurysm"
         </a>
         .)
        </p>
        <p>
         Aneurysmal repair should be considered for asymptomatic aneurysms that are more than twice the size of the normal segment and for aneurysms with enlarging diameter at follow-up. (See
         <a class="medical medical_review" href="/z/d/html/15188.html" rel="external">
          "Management of asymptomatic abdominal aortic aneurysm"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2189786897">
         <span class="h2">
          Screening for diabetes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The USPSTF revised its recommendations regarding screening for diabetes mellitus in 2015. Consistent with these recommendations, we suggest screening for diabetes as part of cardiovascular risk assessment in adults aged 40 to 70 years with body mass index ≥25 kg/m
         <sup>
          2
         </sup>
         [
         <a href="#rid75">
          75
         </a>
         ]. We also suggest screening individuals with hypertension or hyperlipidemia. Screening may be performed by measuring a fasting plasma glucose or, when obtaining a fasting specimen is inconvenient, ordering an A1C (glycated hemoglobin). Abnormal results require a repeat test to confirm the diagnosis of diabetes. (See
         <a class="medical medical_review" href="/z/d/html/1761.html" rel="external">
          "Screening for type 2 diabetes mellitus"
         </a>
         .)
        </p>
        <p>
         No specific evidence exists to support screening for diabetes in those over age 70. Decisions should be based on individual risks and life expectancy, as well as accounting for the potential harms of screening such as overtreatment.
        </p>
        <p class="headingAnchor" id="H94569381">
         <span class="h2">
          Functional and psychosocial evaluation
         </span>
        </p>
        <p class="headingAnchor" id="H94569618">
         <span class="h3">
          Functional assessment and geriatric evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Impairment in activities of daily living is associated with an increased risk of falls, depression, institutionalization, and death in the affected older adult [
         <a href="#rid76">
          76,77
         </a>
         ]. Obtaining a history of functional status, with particular attention to activities of daily living (eg, bathing, toileting, grooming, meal preparation) allows the clinician to focus on potential problem areas. Asking questions targeted at specific conditions that impact function and quality of life may well reduce the morbidity related to these problems  (
         <a class="graphic graphic_table graphicRef64158" href="/z/d/graphic/64158.html" rel="external">
          table 3
         </a>
         ). In addition, measurement of gait speed identifies older adults at high risk of functional decline and poor health [
         <a href="#rid78">
          78
         </a>
         ]. A gait speed faster than 1 meter/second suggests better-than-average life expectancy. (See
         <a class="medical medical_review" href="/z/d/html/17040.html" rel="external">
          "Office-based assessment of the older adult", section on 'Functional assessment'
         </a>
         .)
        </p>
        <p>
         Comprehensive Geriatric Assessment (CGA) can provide a more formal means of identifying key problems and can inform interventions that result in reduced functional decline and improved quality of life [
         <a href="#rid79">
          79,80
         </a>
         ]. However, CGA can be impractical and time-consuming in the primary care setting. (See
         <a class="medical medical_review" href="/z/d/html/3009.html" rel="external">
          "Comprehensive geriatric assessment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H94569719">
         <span class="h3">
          Cognitive assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest that clinicians perform cognitive testing in patients with memory complaints, either self-expressed, or noted by a caregiver or clinician. This is in general agreement with statements from several medical organizations [
         <a href="#rid81">
          81-83
         </a>
         ]. In addition, the National Institute on Aging recommends screening all patients over 80 years old [
         <a href="#rid82">
          82
         </a>
         ] and advocates for the use of structured instruments [
         <a href="#rid84">
          84
         </a>
         ] or algorithms [
         <a href="#rid85">
          85
         </a>
         ] to assist in determining who should be screened. However, we recommend not screening asymptomatic patients, in agreement with the Canadian Task Force on Preventive Health Care [
         <a href="#rid81">
          81
         </a>
         ]. The USPSTF has concluded that there is insufficient evidence to broadly recommend cognitive screening in the general geriatric population [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
         Cognitive testing may allow detection of early or mild dementia when symptoms can be subtle. Detection of early cognitive impairment can be beneficial as it allows for increased awareness of patient safety and behavioral issues and provides an opportunity to implement pharmacologic interventions. In addition, an early diagnosis allows families and loved ones to prepare for caregiving needs and to implement financial and legal planning. Finally, it can facilitate more informed decision-making to optimize quality of life [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         A number of instruments, including the Mini Mental Status Examination, Clock Drawing Test, Mini-Cog, Memory Impairment Screen, Saint Louis University Mental Status Examination, and Montreal Cognitive Assessment are validated screening tools [
         <a href="#rid87">
          87,88
         </a>
         ]. Validated instruments also exist for collecting data from a relative or caregiver of a patient with cognitive decline [
         <a href="#rid89">
          89
         </a>
         ]. A detailed discussion of mental status scales is provided elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14058.html" rel="external">
          "Mental status scales to evaluate cognition"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H927308154">
         <span class="h3">
          Social isolation and loneliness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Older adults may suffer from social isolation due to functional limitations and a lack of relatives, friends, or organizations to provide the physical or emotional support needed to maintain independence and wellbeing. Additionally, those with limited means may be at increased risk due to lack of social connections and resources, such as access to internet and transportation [
         <a href="#rid90">
          90
         </a>
         ]. In a United States cross-sectional survey of 3613 adults age 50 or older using data collected from 2006 to 2016, 19 percent of respondents experienced social isolation, and 18 percent experienced loneliness in the last four years of life [
         <a href="#rid91">
          91
         </a>
         ]. The COVID-19 pandemic likely resulted in further social isolation for many older adults [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Social isolation and loneliness have been associated with adverse health consequences including depression, anxiety, disability, self-rated poor health, and increased risk of death [
         <a href="#rid93">
          93-99
         </a>
         ]. Further, common symptom clusters in older patients may be partially attributable to isolation or loneliness. As an example, in a longitudinal study of 5974 community-dwelling adults 50 years and older, self-reported baseline loneliness was a predictor of subsequent pain (aOR 1.22, 95% CI 1.08-1.37), fatigue (aOR 1.47, 95% CI 1.32-1.65), depression (aOR 2.33, 95% CI 2.02-2.68), and the cluster of all three symptoms (aOR 2.15, 95% CI 1.74 - 2.67) [
         <a href="#rid100">
          100
         </a>
         ]. Clinicians should inquire about and identify social isolation and loneliness in their patients, discuss possible solutions, and provide information about resources [
         <a href="#rid101">
          101
         </a>
         ]. A peer outreach intervention, for isolated older adults reduced feelings of loneliness and improved mood in lower income urban participants [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H94569897">
         <span class="h3">
          Depression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Late-life depression often goes undetected and has a significant adverse impact on quality of life, outcomes of medical disease, health care utilization, morbidity, and mortality [
         <a href="#rid103">
          103
         </a>
         ]. Suicide rates are almost twice as high in the older adult compared with the general population, with the rate highest for White men over 85 years of age. We suggest screening for depression when staff-assisted depression care supports are in place to ensure appropriate diagnosis, treatment, and follow-up. (See
         <a class="medical medical_review" href="/z/d/html/1719.html" rel="external">
          "Diagnosis and management of late-life unipolar depression"
         </a>
         .)
        </p>
        <p>
         The majority of older adults with depression initially present to primary care, often with somatic complaints. Among older adults, depression can present atypically with cognitive, functional, or sleep problems, as well as complaints of fatigue or low energy [
         <a href="#rid103">
          103,104
         </a>
         ].
        </p>
        <p>
         Several short screening instruments have been developed and validated for screening for depression in older adults. (See
         <a class="medical medical_review" href="/z/d/html/1719.html" rel="external">
          "Diagnosis and management of late-life unipolar depression", section on 'Screening instruments'
         </a>
         .)
        </p>
        <p>
         The USPSTF recommends screening all adults for depression, although the optimal screening interval is unknown [
         <a href="#rid105">
          105,106
         </a>
         ]. They also emphasize the importance of having systems in place to provide screening results to the clinician, a readily accessible means of making an accurate diagnosis, and a mechanism for providing treatment and careful follow-up.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Osteoporosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of low bone mineral density (BMD) in older adults is high. Osteopenia is found in 37 percent of postmenopausal women, and osteoporosis (bone mineral density or BMD &gt;2.5 SD below the mean for young women) in 7 percent [
         <a href="#rid107">
          107
         </a>
         ]. We suggest BMD assessment for all women 65 years of age and older and men who have either manifestations of low bone mass (low trauma fractures or loss of height) or risks for fracture (eg, glucocorticoid therapy, androgen deprivation therapy, hyperthyroidism, low body weight, hypogonadism, previous fragility fracture). UpToDate authors prefer screening by dual-energy radiographic absorptiometry (DXA) of hip and spine, though hip alone could be sufficient in older individuals. (See
         <a class="medical medical_review" href="/z/d/html/2046.html" rel="external">
          "Screening for osteoporosis in postmenopausal women and men"
         </a>
         .)
        </p>
        <p>
         UpToDate suggests follow-up DXA as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In adults with low bone mass (T-score -2.00 to -2.49) at any site or who have risk factors for ongoing bone loss (eg, glucocorticoid use, hyperparathyroidism), follow-up measurements approximately every two years, as long as the risk factor persists.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In women 65 years of age and older at baseline screening, with low bone mass (T-score -1.50 to -1.99) at any site, and with no risk factors for accelerated bone loss, follow-up DXA in three to five years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In women 65 years of age and older with normal or slightly low bone mass (T-score -1.01 to -1.49) at baseline measurement and no risk factors for accelerated bone loss, follow-up DXA in 10 to 15 years [
         <a href="#rid108">
          108,109
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The USPSTF recommends that women aged 65 and older be screened routinely for osteoporosis using bone densitometry [
         <a href="#rid110">
          110
         </a>
         ]. The USPSTF also recommends that routine screening begin at age 60 for women at increased risk for osteoporotic fractures, including those with low body weight. (See
         <a class="medical medical_review" href="/z/d/html/2046.html" rel="external">
          "Screening for osteoporosis in postmenopausal women and men"
         </a>
         and
         <a class="local">
          'Society guideline links'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Vision screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Low vision is reported by 15 percent of adults over 75 and is associated with significant declines in health, function, and quality of life. It has also been linked to increased risk of falls, decline in cognition, and increased rates of depression. The USPSTF reviewed the role of screening for vision loss among older adults and found that the evidence was inconclusive to support routine vision screening [
         <a href="#rid111">
          111
         </a>
         ]. Evidence was inconclusive that early detection of visual impairment improved visual outcomes, functional status, or quality of life. Based on this review, there is no clear indication to perform regularly scheduled screenings among otherwise asymptomatic, average-risk older adults. However, we do advise that a vision assessment be included as part of the routine workup for older adults with recent cognitive decline, functional impairment, or falls. (See
         <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">
          "Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis", section on 'Screening'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hearing loss is the third most common ailment, after hypertension and arthritis, to afflict older adults, and is associated with depression, social isolation, poor self-esteem, increased hospitalization rates, cognitive decline, and functional disability [
         <a href="#rid112">
          112-115
         </a>
         ].
        </p>
        <p>
         In 2021, the USPSTF concluded that there was insufficient evidence to determine the balance of benefits and harms of screening for hearing loss in asymptomatic older adults aged 50 years or older [
         <a href="#rid116">
          116
         </a>
         ]. Despite the insufficient evidence, we suggest that primary providers screen adults over 65 for hearing loss, and in particular, vulnerable older adults at risk for functional decline, hospitalization, or cognitive problems [
         <a href="#rid113">
          113
         </a>
         ].
        </p>
        <p>
         Patient inquiry is a rapid and inexpensive way to screen for hearing loss. While pure tone audiometry is the reference standard for screening hearing, a whispered voice test is both sensitive and specific [
         <a href="#rid117">
          117
         </a>
         ]. An evidence review to support a recommendation from the USPSTF found that either the whispered voice test at two feet or a single question regarding perceived hearing loss were nearly as effective as a formal hearing questionnaire or use of a tone-emitting otoscope for the detection of hearing loss [
         <a href="#rid118">
          118
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6850.html" rel="external">
          "Evaluation of hearing loss in adults", section on 'Office hearing evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15359.html" rel="external">
          "Presbycusis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h2">
          Nutrition
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many major authorities on health care maintenance, including the Canadian Task Force, ACP [
         <a href="#rid119">
          119
         </a>
         ], and American Academy of Family Physicians, recommend that clinicians routinely provide nutritional assessment and counseling to their patients.
        </p>
        <p>
         Approximately 15 percent of older outpatients and half of the hospitalized older adults are malnourished [
         <a href="#rid120">
          120
         </a>
         ]. Despite the clear relationship between undernutrition and increased morbidity and mortality [
         <a href="#rid121">
          121
         </a>
         ], there are no well-validated general laboratory screens for this condition. A combination of serial weight measurements obtained in the office and inquiry about changing appetite are likely the most useful methods of assessing nutritional status in older patients. In addition, a mini-nutritional assessment tool has been developed to help the clinician determine patients who may need nutritional support and counseling  (
         <a class="graphic graphic_figure graphicRef79831" href="/z/d/graphic/79831.html" rel="external">
          figure 3
         </a>
         ).
        </p>
        <p>
         Vulnerable older adults with an involuntary weight loss of 10 percent or more in less than a year should undergo further evaluation for undernutrition, possible medical or medication-related causes, dental status, food security, food-related functional status, appetite and intake, swallow ability, and previous dietary restrictions [
         <a href="#rid122">
          122
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3016.html" rel="external">
          "Geriatric nutrition: Nutritional issues in older adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2634929">
         <span class="h3">
          Vitamin D
         </span>
         <span class="headingEndMark">
          —
         </span>
         A growing evidence base has identified the high prevalence of vitamin D deficiency (&lt;30 ng/mL) among older adults and important health implications [
         <a href="#rid123">
          123
         </a>
         ]. The role of vitamin D in falls prevention is uncertain, although most experts advise that the daily intake of vitamin D in older adults should be at least 800 international units. However, evidence suggests that high dose intermittent vitamin D (24,000 international units or greater) may increase fall risk [
         <a href="#rid124">
          124
         </a>
         ]. At least 1.2 g of elemental calcium in the diet or as a supplement is also recommended. (See
         <a class="medical medical_review" href="/z/d/html/2023.html" rel="external">
          "Calcium and vitamin D supplementation in osteoporosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3014.html" rel="external">
          "Falls: Prevention in community-dwelling older persons"
         </a>
         .)
        </p>
        <p>
         It appears that vitamin D plus calcium may reduce the risk of hip fracture in older adults. Although the large Women's Health Initiative found that calcium and vitamin D was not effective in reducing fractures in healthy postmenopausal women over a seven-year follow-up [
         <a href="#rid125">
          125
         </a>
         ], two meta-analyses have found that vitamin D and calcium decreased the relative risk of fractures [
         <a href="#rid126">
          126,127
         </a>
         ].
        </p>
        <p>
         However, in a three-year European trial among 2157 healthy adults aged 70 years or older (DO-HEALTH), treatment with 2000 international units per day of
         <a class="drug drug_general" data-topicid="10117" href="/z/d/drug information/10117.html" rel="external">
          vitamin D3
         </a>
         , 1 g per day of EPA/DHA omega-3 fatty acids, or a strength-training exercise program, either alone or in combination, did not improve health outcomes of systolic or diastolic blood pressure, nonvertebral fractures, physical performance, infection rates, or cognitive function [
         <a href="#rid128">
          128
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2634936">
         <span class="h3">
          Multivitamins
         </span>
         <span class="headingEndMark">
          —
         </span>
         No prospective randomized data supports an effect of multivitamins on morbidity or mortality. Multivitamin supplementation has the potential to provide benefit for those older individuals whose nutritional intake is insufficient. However, observational studies have suggested that multivitamin supplements do not decrease the risk for cancer or cardiovascular disease, and one large cohort study suggested the possibility of increased mortality in healthy older women who reported taking vitamin supplements [
         <a href="#rid129">
          129
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">
          "Vitamin intake and disease prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h2">
          Falls and mobility
         </span>
         <span class="headingEndMark">
          —
         </span>
         Providers should regularly ask older patients about recent falls and fall risks because of the high incidence and potential sequelae of falls, including fracture or hospitalization. Methods and specific in-office tests to assess fall risks are described in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3012.html" rel="external">
          "Falls in older persons: Risk factors and patient evaluation", section on 'Evaluation for patients with increased fall risk'
         </a>
         .)
        </p>
        <p>
         For patients who fall or have problems in physical functioning or limited mobility that increase their risk for falls, clinicians should assess for contributory factors, review medications, and ask about home safety. (See
         <a class="medical medical_review" href="/z/d/html/3012.html" rel="external">
          "Falls in older persons: Risk factors and patient evaluation"
         </a>
         .)
        </p>
        <p>
         Effective interventions for people with a history of falls or risks for falling, including physical therapy, assistive devices, and a supervised exercise program, are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3014.html" rel="external">
          "Falls: Prevention in community-dwelling older persons"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h2">
          Incontinence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urinary incontinence (UI) causes major social and emotional distress in older adults and is a major factor in nursing home placement. UI is estimated to affect 11 to 34 percent of older men and 17 to 55 percent of older women [
         <a href="#rid130">
          130
         </a>
         ]. Diabetes approximately doubles the risk for severe incontinence in women [
         <a href="#rid131">
          131
         </a>
         ]. Continence problems are potentially treatable [
         <a href="#rid132">
          132
         </a>
         ] but are often not raised by patients as a concern [
         <a href="#rid133">
          133
         </a>
         ].
        </p>
        <p>
         A targeted history and physical examination can often identify the cause of UI and lead to appropriate intervention. We ask about and document the presence or absence of UI biannually, and determining whether the UI, if present, is bothersome to the patient or caregiver. Appropriate assessment includes questions to determine UI onset (acute versus chronic), type (eg, stress, urge, overflow, mixed), and precipitants (eg, cough, medication use). A targeted physical might include assessment for fluid overload, genital and rectal examination, and neurologic evaluation. Urine and blood tests are indicated to evaluate for infection, metabolic causes, renal dysfunction, and possible vitamin B12 deficiency. Routine urodynamic testing is not recommended. (See
         <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">
          "Female urinary incontinence: Evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6881.html" rel="external">
          "Female urinary incontinence: Treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114501.html" rel="external">
          "Urgency urinary incontinence/overactive bladder (OAB) in females: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1278760477">
         <span class="h1">
          SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sexual activity remains an important part of the quality of life of older adults. As such, a significant percentage of older adults are sexually active and may remain at risk for sexually transmitted and bloodborne infections (STIs). Rates of STIs have increased significantly over the last decade. In addition to routinely inquiring about sexual health and safety, specific consideration should be given to the following [
         <a href="#rid134">
          134
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatitis B
         </strong>
         – In general, we suggest one-time universal screening for hepatitis B virus for adults &gt;18 years of age. Unvaccinated persons at increased risk may need repeated screening  (
         <a class="graphic graphic_table graphicRef55052" href="/z/d/graphic/55052.html" rel="external">
          table 4
         </a>
         ). More detailed information on hepatitis B screening is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/3680.html" rel="external">
          "Hepatitis B virus: Screening and diagnosis in adults", section on 'Approach to screening and testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatitis C
         </strong>
         – We recommend a one-time screening for all United States adults ages between 18 to 79 years. Rescreening is appropriate for those with risk factors that may result in continued exposure to hepatitis C; this is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/89950.html" rel="external">
          "Screening and diagnosis of chronic hepatitis C virus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89950.html" rel="external">
          "Screening and diagnosis of chronic hepatitis C virus infection", section on 'Those with ongoing risk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Human immunodeficiency virus (HIV) infection
         </strong>
         – We recommend screening adults for HIV infection until age 75. (See
         <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">
          "Screening and diagnostic testing for HIV infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Prevention and screening for other STIs are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/97819.html" rel="external">
          "Overview of preventive care in adults", section on 'Sexually transmitted and bloodborne infections'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h1">
          MEDICATION USE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Problems related to medication use are common in older adults. Adults over age 65 in the United States take an average of three to five medications [
         <a href="#rid135">
          135
         </a>
         ]. Use of multiple medications increases the risk for drug-drug interactions and associated adverse drug events. Altered pharmacokinetics and pharmacodynamics in older adults contribute to adverse drug events, a common cause of hospitalization and morbidity in older patients [
         <a href="#rid136">
          136
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3013.html" rel="external">
          "Drug prescribing for older adults"
         </a>
         .)
        </p>
        <p>
         Evidence-based recommendations on medication management include  (
         <a class="graphic graphic_table graphicRef73834" href="/z/d/graphic/73834.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid137">
          137
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maintain an up-to-date medication list, including over-the-counters and herbals.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comprehensively review medications at least once annually (if not at every visit) and after all hospitalizations. A clear indication for each medication, and documentation of response to therapy (particularly for chronic conditions), should be included.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assess for duplication, drug-drug or drug-disease interactions, adherence, and affordability.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assess for specific classes of medications commonly associated with adverse events: anticoagulants, analgesics (particularly narcotics and nonsteroidal antiinflammatory drugs), antihypertensives (particularly angiotensin-converting enzyme [ACE] inhibitors and diuretics), insulin and hypoglycemic agents, and any psychotropics.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Minimize or avoid use of anticholinergic medications which present specific risks.
        </p>
        <p>
        </p>
        <p>
         The Beer's Criteria for Potentially Inappropriate Medication Use in Older Adults, updated in 2019, also provides a list of commonly encountered problem medications [
         <a href="#rid138">
          138
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3013.html" rel="external">
          "Drug prescribing for older adults"
         </a>
         .)
        </p>
        <p>
         An approach to deprescribing is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/122694.html" rel="external">
          "Deprescribing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2090887445">
         <span class="h1">
          HOME SAFETY ASSESSMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2012 to 2013, over 90,000 older adults in the United States died as a result of unintentional injury [
         <a href="#rid139">
          139
         </a>
         ]. Over one-half these were due to falls and another 14 percent due to motor vehicle accidents. Additional causes included poisoning, fire, and suffocation. Common physical and cognitive problems predispose older adults to higher rates of accidents in the home. After an accident, older adults are less likely to get prompt assistance or needed medical help because of their increased risk of isolation and problems with communication.
        </p>
        <p>
         Evidence is not robust on how to best reduce risk of injury. Home safety intervention trials have largely focused on fall prevention and have had mixed results, likely due to the multifactorial and personalized nature of assessments and interventions [
         <a href="#rid140">
          140
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3014.html" rel="external">
          "Falls: Prevention in community-dwelling older persons"
         </a>
         .)
        </p>
        <p>
         Nonetheless, several brief self-administered checklists may be provided to patients and families or other household members to help in raising awareness and meeting the Medicare Annual Wellness Visit requirement for safety evaluation (
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fsteadi%2Fpdf%2Fcheck_for_safety_brochure-a.pdf&amp;token=ACrQ7Nkdl%2Bf2n5%2FHOwGJcCzIMadx0QJ2lYz%2Bj9vjvxKDqQ%2BfU60hQtY2Tae38ouQOWpZQEIhBEe2EE3zrikj8ZxgPzqbDfyRpqGPtL8L6hE%3D&amp;TOPIC_ID=3017" target="_blank">
          A Home Fall Prevention Checklist for Older Adults
         </a>
         and
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncoa.org%2Fadviser%2Fmedical-alert-systems%2Fhome-safety-older-adults%2F&amp;token=aueAf9ezIMA5zjipTcoVn3eyc9UMmAUxrcFYESEgMnYySOXugMCuWKpsnrzJRihqTxnfOgqY0O6de09FoToHYzKCEK58GVH3dwp2XrYre3M%3D&amp;TOPIC_ID=3017" target="_blank">
          Home Safety Tips for Older Adults
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          DRIVING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adults over age 70 suffer more motor vehicle accidents and more fatal driver and pedestrian accidents per one million miles driven than middle-aged drivers. This is likely a result of factors such as a decline in visual acuity, hearing, and psychomotor skills [
         <a href="#rid141">
          141
         </a>
         ]. The American Medical Association offers a specific online publication to guide assessment of the older driver [
         <a href="#rid142">
          142
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3005.html" rel="external">
          "Approach to the evaluation of older drivers"
         </a>
         .)
        </p>
        <p>
         Clinicians should discuss driving with all patients diagnosed with dementia, and either recommend stopping driving or refer for formal driving assessment by occupational therapy. A diagnosis of dementia independently increases the risk of a motor vehicle accident (odds ratio 2.4 to 4.7) [
         <a href="#rid143">
          143
         </a>
         ]. Specific reporting laws vary by state. The American Academy of Neurology has issued guidelines for driving in patients with Alzheimer disease based on the clinical dementia rating [
         <a href="#rid144">
          144
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5080.html" rel="external">
          "Management of the patient with dementia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h1">
          FINANCIAL AND SOCIAL SUPPORT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Providers should screen for problems with financial and social resources, as these issues have direct implications for health status and wellbeing. The older adult United States population varies widely in measures of wealth and social support. While the overall rate of poverty among adults over age 65 has declined over the last 50 years, 10 percent of older adults still live at or below the poverty line, with higher rates among Black (18 percent) and Hispanic (17 percent) older adults [
         <a href="#rid145">
          145
         </a>
         ].
        </p>
        <p>
         Most communities have social support assistance available through Area Agencies on Aging or other municipal organizations. Information can be gathered online at the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Feldercare.acl.gov%2FPublic%2FIndex.aspx&amp;token=Knph9ZFfUwgP0BQgsy2O5u7dBja%2FS%2FoHmpZmKas5hB2LRLj0J8h9YZcSpK8wRPIRT%2B%2B%2BVq0wHvBG7%2FO0VQ%2FvtA%3D%3D&amp;TOPIC_ID=3017" target="_blank">
          Eldercare Locator
         </a>
         .
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h1">
          ELDER MISTREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Elder mistreatment has been reported in 3 to 8 percent of the older adult population in the United States [
         <a href="#rid146">
          146
         </a>
         ]. A variety of forms of neglect or physical abuse (physical, sexual, psychological, financial, neglect) can result in adverse health outcomes for older victims, including increased mortality [
         <a href="#rid147">
          147
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3007.html" rel="external">
          "Elder abuse, self-neglect, and related phenomena"
         </a>
         .)
        </p>
        <p>
         Victims themselves are unlikely to report instances of abuse, making it difficult to address issues in the clinical setting. Older adults who are noted to have contusions, burns, bite marks, genital or rectal trauma, pressure ulcers, or a body mass index &lt;17.5 without clinical explanation should be asked about mistreatment or referred to social work services [
         <a href="#rid25">
          25
         </a>
         ]. Available screening tools may also help clinicians discriminate cases of abuse or neglect.
        </p>
        <p>
         The American Medical Association and the United States Preventive Services Task Force (USPSTF) recommend that clinicians routinely ask older patients direct, specific questions about abuse [
         <a href="#rid105">
          105,148
         </a>
         ], although the USPSTF finds insufficient evidence to recommend for or against the use of screening instruments [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H34">
         <span class="h1">
          ADVANCE DIRECTIVES AND HEALTH CARE PROXY
         </span>
         <span class="headingEndMark">
          —
         </span>
         A discussion of end-of-life care is well-suited to the health maintenance examination when the focus may be less on specific disease and more on prevention and planning. While addressing these issues can be complex and time-consuming, specific CPT codes to bill for discussions of 30 minutes or more focused on advance care planning affords providers in the United States an opportunity to address these vital concerns [
         <a href="#rid149">
          149
         </a>
         ]. Older patients may experience periods of altered sensorium or cognitive impairment and become unable to participate in their financial or health care decisions. Powers of attorney, living wills, advanced directives, and guardianship documents become important in these situations. (See
         <a class="medical medical_review" href="/z/d/html/86248.html" rel="external">
          "Advance care planning and advance directives"
         </a>
         .)
        </p>
        <p>
         A power of attorney designates a surrogate who is authorized to manage a patient's financial affairs. A health care power of attorney designates a representative to make health care choices for the patients. For patients who have not created a health care power of attorney, the spouse or other first-degree relative typically is the default surrogate decision-maker. The patient's preferences are sometimes detailed in a living will or other more detailed advance directive. Examples include out-of-facility Do Not Resuscitate (DNR) order forms, the Physician Orders for Life-Sustaining Treatment (POLST), Medical Orders for Scope of Treatment (MOST), and Medical Orders for Life-Sustaining Treatment (MOLST) forms. These documents may address situations in which the patient has a terminal illness, persistent vegetative state, or progressive neurologic condition and can include explicit directions for care management including withdrawal or withholding specific measures such as artificial nutrition or hydration. If no surrogate is designated and next-of-kin is not available, guardianship may be obtained. Guardianship is a legal proceeding whereby the court appoints a surrogate decision-maker. (See
         <a class="medical medical_review" href="/z/d/html/2202.html" rel="external">
          "Ethical issues in palliative care"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4271794">
         <span class="h1">
          MEDICARE AND PREVENTIVE VISITS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2005, the Medicare Modernization Act (MMA) authorized full payment for an Initial Preventive Physical Examination (IPPE), also known as the "Welcome to Medicare Preventive Visit." This examination is for new Medicare beneficiaries and is focused on identifying and mitigating health risks and educating patients about available preventive services. Updated in 2011, a qualifying IPPE requires performance of seven key components, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medical and surgical history
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for depression or other mood disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Functional ability and safety
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical examination to include height, weight, body mass index, blood pressure, visual acuity, and other relevant elements
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         End-of-life planning
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Education, counseling, and referral based on issues identified
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Orientation to available preventive services
        </p>
        <p>
        </p>
        <p>
         As a part of its documentation, the visit results in a written plan shared with patients detailing recommendations and referrals.
        </p>
        <p>
         A brief written guide to the IPPE is available online from the Centers for Medicare &amp; Medicaid (CMS) at
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cms.gov%2FOutreach-and-Education%2FMedicare-Learning-Network-MLN%2FMLNProducts%2Fpreventive-services%2Fmedicare-wellness-visits.html&amp;token=MtBJtiZHQRtqkdcmdivGE6P%2BgHcc64exnVGyKgDdqz9mekAbsQwnqVOdnHHknJuj4F48pYWwP%2FxkFGphWQY72krMaRJ%2BXBkkY08RvvdjFaP0iIc8jt0lF9SV3FWeh0v7D535RabpKu3wMmuufVWaqnxlHqVCenAVBG71VvlGO%2FQ%3D&amp;TOPIC_ID=3017" target="_blank">
          The ABCs of the Initial Preventive Physical Examination (IPPE)
         </a>
         [
         <a href="#rid150">
          150
         </a>
         ].
        </p>
        <p>
         The MMA legislation also provides for a follow-up Annual Wellness Visit after each 12-month period to continue to monitor and build on the plan created as part of the IPPE. A brief written guide to the Medicare Annual Wellness Visit ("The ABCs of the Annual Wellness Visit") is available
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cms.gov%2FOutreach-and-Education%2FMedicare-Learning-Network-MLN%2FMLNProducts%2Fpreventive-services%2Fmedicare-wellness-visits.html&amp;token=MtBJtiZHQRtqkdcmdivGE6P%2BgHcc64exnVGyKgDdqz9mekAbsQwnqVOdnHHknJuj4F48pYWwP%2FxkFGphWQY72krMaRJ%2BXBkkY08RvvdjFaP0iIc8jt0lF9SV3FWeh0v7D535RabpKu3wMmuufVWaqnxlHqVCenAVBG71VvlGO%2FQ%3D&amp;TOPIC_ID=3017" target="_blank">
          online
         </a>
         from the CMS.
        </p>
        <p class="headingAnchor" id="H35">
         <span class="h1">
          RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For a number of years, the United States Preventive Services Task Force (USPSTF) has developed and revised specific clinical recommendations regarding health maintenance for all populations in the United States [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
         Over the last decade, several resources have emerged to define priorities for prevention and promotion specifically among older adults. Healthy People 2030 defines specific targets for the older adult population nationwide [
         <a href="#rid151">
          151
         </a>
         ].
        </p>
        <p>
         Guidelines with regard to interval screening for specific malignancies are available from the USPSTF, American Cancer Society (ACS) [
         <a href="#rid42">
          42,105
         </a>
         ], and others. ACS recommendations are generally more supportive of cancer screening programs than are those of other groups.
        </p>
        <p>
         The American Geriatric Society offers an online archive of information related to geriatric screening and health maintenance issues [
         <a href="#rid152">
          152
         </a>
         ].
        </p>
        <p>
         The Institute for Healthcare Improvement, in partnership with the John A Hartford Foundation, has launched the Age-Friendly Health Systems initiative with online guides about improving care of older adults by focusing on the "4Ms" (Mobility, Mentation, Medications, what Matters). Resources are available
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ihi.org%2FEngage%2FInitiatives%2FAge-Friendly-Health-Systems%2FPages%2Fdefault.aspx&amp;token=SQnyzTT56ISH32d%2BGFISOgofgomdXtC%2FhpM8MHS%2FQVXcr8rb93%2BcK6rgO8vNGZjLN6yBipYX%2FG6f1YIkONoZWE6ffP56oksnXgUKKz68aRwYPdhJXBMz8OWoEVbTd57J&amp;TOPIC_ID=3017" target="_blank">
          online
         </a>
         [
         <a href="#rid153">
          153
         </a>
         ].
        </p>
        <p>
         Information on legal issues and the older patient is available from the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.naela.org%2F%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2F2cEwO%2Fvpi60vBRAItHm0vw%3D&amp;TOPIC_ID=3017" target="_blank">
          National Academy of Elder Law Attorneys
         </a>
         .
        </p>
        <p class="headingAnchor" id="H36">
         <span class="h1">
          PATIENT RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Agency for Healthcare Research and Quality has prepared a booklet for older adults called "The Pocket Guide to Staying Healthy at 50+." There are separate guides for
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.ahrq.gov%2Fsites%2Fdefault%2Ffiles%2Fpublications%2Ffiles%2Fmen-over-50.pdf&amp;token=aRBh1nwB24IwCiVepyZ0eJbx4u5jdVfRG3Z%2FZtzHWs5k7%2BuC1e%2FYV1Ih576ZAaFjg6zIWRzpzWHK6MGLY7FlfdaJRIQAuh5kutcDpQi20lM%3D&amp;TOPIC_ID=3017" target="_blank">
          men
         </a>
         and
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.ahrq.gov%2Fsites%2Fdefault%2Ffiles%2Fpublications%2Ffiles%2Fwomen-over-50.pdf&amp;token=%2BaMvjHNzqI1KbGGzzLVaT9jdiweyyZ6MgH0YETGKXBgMBlQbs%2F7KnScvIyOZSZZG3OVwe0O0lVaJQTHCCo756BUJRNlj%2Bt939hgtq51B3KM%3D&amp;TOPIC_ID=3017" target="_blank">
          women
         </a>
         .
        </p>
        <p>
         Through its Health in Aging Foundation, the American Geriatrics Society has created an informational
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.healthinaging.org%2F&amp;token=sL%2Bp%2BgWoM5K8OZ3TcR7z2bv7DM5JyJoociI9KsVX2M8KJmpjXrcUrqd6PB5sNDWi&amp;TOPIC_ID=3017" target="_blank">
          website
         </a>
         for patients and caregivers.
        </p>
        <p>
         The National Institute on Aging provides free
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Forder.nia.nih.gov%2F&amp;token=fqdOYbvrduvv7dqKXOrgElSy1Qkp6fU5snXrxaTLPJqvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=3017" target="_blank">
          pamphlets
         </a>
         , as part of its AgePage series, on other common issues in older adults.
        </p>
        <p>
         Information for patients about the Medicare Initial Preventive Physical Examination (IPPE) is available on the Medicare
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.medicare.gov%2Fcoverage%2Fwelcome-to-medicare-preventive-visit&amp;token=IVT%2BNhhZx8G2Sjh6KIA02cKrM0i454bydUsR4zUWWN0aaGw22lRbI9JVHNB5fZ8hWGvN7JqiXNo4XlRCDoMnZRUj%2BCesOjK4Gu3C6ONk1IA%3D&amp;TOPIC_ID=3017" target="_blank">
          website
         </a>
         .
        </p>
        <p class="headingAnchor" id="H923762468">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109391.html" rel="external">
          "Society guideline links: Falls"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/105492.html" rel="external">
          "Society guideline links: Osteoporosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4946078">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16621.html" rel="external">
          "Patient education: Preventive health care for older adults (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H37">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Goals of care for older adults
         </strong>
         – The wide heterogeneity in health states among older adults means that treatment decisions, both preventive and therapeutic, should be based on individual needs. Age alone should not be the sole determinant for many interventions, and all treatments should aim to preserve function and maximize quality of life. (See
         <a class="local">
          'Goals of care for older adults'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A summary of recommendations for specific conditions is presented in a table  (
         <a class="graphic graphic_table graphicRef75220" href="/z/d/graphic/75220.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Overview of prevention for older adults'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Healthy lifestyle
         </strong>
         – Healthy lifestyle measures supported by evidence and current guideline recommendations include (a) exercise to include aerobic activity 30 minutes daily for at least five days a week, muscle strengthening, and balance training; (b) smoking cessation; and (c) limiting alcohol intake. (See
         <a class="local">
          'Healthy lifestyle'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunizations
         </strong>
         – Immunization schedules should include annual influenza vaccination, pneumococcal vaccination, and herpes zoster vaccine after age 50. We encourage vaccination to prevent COVID-19. Older adults who have not received a Tdap (tetanus, diphtheria, acellular pertussis) should receive a one-time Tdap booster after age 65 as well. (See
         <a class="local">
          'Immunizations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cancer screening
         </strong>
         – Cancer screening decisions should be based on assessment of risk and benefit as well as individual preference and life expectancy. For women who choose to undergo screening after counseling about harms and benefits, biennial screening mammography may be offered for those with at least 10 years of life expectancy. Screening for colorectal cancer (CRC) is indicated beginning at age 45, using one of the several tests effective for CRC screening, with timing of discontinuation of screening based on health status. (See
         <a class="local">
          'Cancer screening'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular disease screening
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Screening for hypertension is recommended annually. Screening for hyperlipidemia is most strongly recommended for those with known cardiovascular disease, and certain risk factors make screening for abdominal aortic aneurysm and diabetes appropriate. (See
         <a class="local">
          'Cardiovascular screening'
         </a>
         above and
         <a class="local">
          'Screening for diabetes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other screening
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monitor for symptoms and conditions that often impact health, safety, and quality in late life, including cognitive impairment, depression, gait instability and falls, vision and hearing loss, poor nutrition, weight loss, social isolation or loneliness, and functional decline. (See
         <a class="local">
          'Hearing loss'
         </a>
         above and
         <a class="local">
          'Vision screening'
         </a>
         above and
         <a class="local">
          'Functional and psychosocial evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Screen for osteoporosis in all women age 65 or older as well as men with risk factors. (See
         <a class="local">
          'Osteoporosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medication use
         </strong>
         – Regularly perform medication reconciliation to include assessment of indications, adverse effects, interactions, and cost of prescription and nonprescription medications and supplements. (See
         <a class="local">
          'Medication use'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Safety and financial security
         </strong>
         – Inquire about elder abuse, driving safety, and financial security. (See
         <a class="local">
          'Elder mistreatment'
         </a>
         above and
         <a class="local">
          'Driving'
         </a>
         above and
         <a class="local">
          'Financial and social support'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Advance care planning
         </strong>
         – Establish and maintain advance directives, updating goals and preferences for care as health conditions and life circumstances evolve in late life. (See
         <a class="local">
          'Advance directives and health care proxy'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America 2007. The Merck Company Foundation, Whitehouse Station, NJ 2007. Available at: http://www.cdc.gov/aging/pdf/saha_2007.pdf (Accessed on April 12, 2012).
         </li>
         <li class="breakAll">
          United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2013. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf (Accessed on August 25, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cigolle CT, Langa KM, Kabeto MU, et al. Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 2007; 147:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA 2013; 310:2609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schonberg MA, Leveille SG, Marcantonio ER. Preventive health care among older women: missed opportunities and poor targeting. Am J Med 2008; 121:974.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA 2005; 294:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuben DB. Medical care for the final years of life: "When you're 83, it's not going to be 20 years". JAMA 2009; 302:2686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Artaud F, Dugravot A, Sabia S, et al. Unhealthy behaviours and disability in older adults: three-City Dijon cohort study. BMJ 2013; 347:f4240.
          </a>
         </li>
         <li class="breakAll">
          US Department of Health and Human Services. Healthy People 2010, conference edition. Washington DC: U.S. Department of Health and Human Services; 2000. Available at: www.healthypeople.gov (Accessed on December 21, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           King AC, Guralnik JM. Maximizing the potential of an aging population. JAMA 2010; 304:1944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dipietro L, Campbell WW, Buchner DM, et al. Physical Activity, Injurious Falls, and Physical Function in Aging: An Umbrella Review. Med Sci Sports Exerc 2019; 51:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolfson L, Whipple R, Derby C, et al. Balance and strength training in older adults: intervention gains and Tai Chi maintenance. J Am Geriatr Soc 1996; 44:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf SL, Barnhart HX, Kutner NG, et al. Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention Techniques. J Am Geriatr Soc 1996; 44:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doolan DM, Froelicher ES. Efficacy of smoking cessation intervention among special populations: review of the literature from 2000 to 2005. Nurs Res 2006; 55:S29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burns DM. Cigarette smoking among the elderly: disease consequences and the benefits of cessation. Am J Health Promot 2000; 14:357.
          </a>
         </li>
         <li class="breakAll">
          Health benefits of smoking cessation: a report of the Surgeon General 1990. Centers for Disease Control; Office on Smoking and Health, 1990.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J 1979; 2:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 2012; 172:837.
          </a>
         </li>
         <li class="breakAll">
          Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication. USPSTF. Release Date: March 2009. http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication (Accessed on October 06, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elhassan A, Chow RD. Smoking cessation in the elderly. Clin Geriatr 2007; 15:38.
          </a>
         </li>
         <li class="breakAll">
          Clinical guidelines for alcohol use disorders in older adults. American Geriatrics Society (AGS) Position Statement. American Geriatrics Society, New York 2003.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SR, Knowles SB, Huang Q, Fink A. The prevalence of harmful and hazardous alcohol consumption in older U.S. adults: data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES). J Gen Intern Med 2014; 29:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gnanadesigan N, Fung CH. Quality indicators for screening and prevention in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl 2:S417.
          </a>
         </li>
         <li class="breakAll">
          Helping Patients Who Drink Too Much, a Clinician's Guide. 2005. Available at: www.niaaa.nih.gov/guide (Accessed on January 10, 2008).
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. JAMA 2022; 327:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moayyedi P, Eikelboom JW, Bosch J, et al. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology 2019; 157:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 118:1894.
          </a>
         </li>
         <li class="breakAll">
          https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/older-adults.html (Accessed on October 22, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Tetanus--Kansas, 1993. MMWR Morb Mortal Wkly Rep 1994; 43:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018; 67:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomonova K, Vizev S. Secondary response to boostering by purified aluminium-hydroxide-adsorbed tetanus anatoxin in aging and in aged adults. Immunobiology 1981; 158:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis. J Gen Intern Med 1993; 8:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marlovits S, Stocker R, Efstratiou A, et al. Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults. Eur J Clin Microbiol Infect Dis 2000; 19:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778.
          </a>
         </li>
         <li class="breakAll">
          CDC's Advisory Committee on Immunization Practices (ACIP) recommends universal annual influenza vaccination. Available at: http://www.cdc.gov/media/pressrel/2010/r100224.htm (Accessed on May 16, 2010).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network: Streptococcus pneumoniae, 2010 (ORIG). http://www.cdc.gov/abcs/reports-findings/survreports/spneu10-orig.pdf (Accessed on March 21, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007; 356:1338.
          </a>
         </li>
         <li class="breakAll">
          FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine. US Food &amp; Drug Administration (FDA) approved product information. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine (Accessed on May 04, 2023).
         </li>
         <li class="breakAll">
          ABRYSVO (Respiratory Syncytial Virus Vaccine) solution for
intramuscular injection. US Food and Drug Administration (FDA) approved product information. Available at: https://www.fda.gov/media/168889/download (Accessed on June 02, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albert RH, Clark MM. Cancer screening in the older patient. Am Fam Physician 2008; 78:1369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clarfield AM. Screening in frail older people: an ounce of prevention or a pound of trouble? J Am Geriatr Soc 2010; 58:2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lansdorp-Vogelaar I, Gulati R, Mariotto AB, et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 2014; 161:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alibhai SMH, Horgan AM. Cancer screening in older adults: What to do when we don't know. J Geriatr Oncol 2011; 2:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snyder AH, Magnuson A, Westcott AM. Cancer Screening in Older Adults. Med Clin North Am 2016; 100:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schonberg MA, Jacobson AR, Karamourtopoulos M, et al. Scripts and Strategies for Discussing Stopping Cancer Screening with Adults &gt; 75 Years: a Qualitative Study. J Gen Intern Med 2020; 35:2076.
          </a>
         </li>
         <li class="breakAll">
          US Preventive Services Task Force. Final recommendation statement: Prostate cancer: Screening. 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening1 (Accessed on November 24, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014; 311:1327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA 2014; 311:1336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schonberg MA, Hamel MB, Davis RB, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med 2014; 174:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braithwaite D, Zhu W, Hubbard RA, et al. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst 2013; 105:334.
          </a>
         </li>
         <li class="breakAll">
          Choosing Wisely - American Geriatrics Society: Ten Things Clinicians and Patients Should Question http://www.choosingwisely.org/societies/american-geriatrics-society/ (Accessed on August 24, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawaya GF, Sung HY, Kearney KA, et al. Advancing age and cervical cancer screening and prognosis. J Am Geriatr Soc 2001; 49:1499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fletcher A. Screening for cancer of the cervix in elderly women. Lancet 1990; 335:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherlaw-Johnson C, Gallivan S, Jenkins D. Withdrawing low risk women from cervical screening programmes: mathematical modelling study. BMJ 1999; 318:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fahs MC, Mandelblatt J, Schechter C, Muller C. Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med 1992; 117:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Power EJ. Pap smears, elderly women, and Medicare. Cancer Invest 1993; 11:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Celentano DD, Shapiro S, Weisman CS. Cancer preventive screening behavior among elderly women. Prev Med 1982; 11:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandelblatt J, Schechter C, Fahs M, Muller C. Clinical implications of screening for cervical cancer under Medicare. The natural history of cervical cancer in the elderly: what do we know? What do we need to know? Am J Obstet Gynecol 1991; 164:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinrich S, Coker AL, Weinrich M, et al. Predictors of Pap smear screening in socioeconomically disadvantaged elderly women. J Am Geriatr Soc 1995; 43:267.
          </a>
         </li>
         <li class="breakAll">
          Gluck ME, Wagner JL, Duffy BM. The use of preventive services by the elderly. Preventive Health Services under Medicare series, Paper 2. Office of Technology Assessment; Washington, DC 1989.
         </li>
         <li>
          <a class="nounderline abstract_t">
           National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46:5.
          </a>
         </li>
         <li class="breakAll">
          USPSTF Final Recommendation Statement High Blood Pressure in Adults: Screening https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/high-blood-pressure-in-adults-screening (Accessed on June 11, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali R, Alexander KP. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Am J Geriatr Pharmacother 2007; 5:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360:1623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA 2014; 312:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashton HA, Buxton MJ, Day NE, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360:1531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim LG, P Scott RA, Ashton HA, et al. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007; 146:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995; 82:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siu AL, U S Preventive Services Task Force. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015; 163:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manton KG. A longitudinal study of functional change and mortality in the United States. J Gerontol 1988; 43:S153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med 1992; 93:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011; 305:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuo HK, Scandrett KG, Dave J, Mitchell SL. The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis. Arch Gerontol Geriatr 2004; 39:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002; 346:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canadian Task Force on Preventive Health Care, Pottie K, Rahal R, et al. Recommendations on screening for cognitive impairment in older adults. CMAJ 2016; 188:37.
          </a>
         </li>
         <li class="breakAll">
          National Institute on Aging: Assessing Cognitive Impairment in Older Patients. www.nia.nih.gov/health/assessing-cognitive-impairment-older-patients (Accessed on January 12, 2019).
         </li>
         <li class="breakAll">
          National Institute for Health and Care Excellence: Dementia: Assessment, management and support for people living with dementia and their carers. NG97, 2018. www.nice.org.uk/guidance/ng97/resources/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109 (Accessed on January 12, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes DE, Beiser AS, Lee A, et al. Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement 2014; 10:656.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordell CB, Borson S, Boustani M, et al. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement 2013; 9:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moyer VA, U.S. Preventive Services Task Force. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin JS, O'Connor E, Rossom RC, et al. Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013; 159:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holsinger T, Deveau J, Boustani M, Williams JW Jr. Does this patient have dementia? JAMA 2007; 297:2391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr 2004; 16:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Escalante E, Golden RL, Mason DJ. Social Isolation and Loneliness: Imperatives for Health Care in a Post-COVID World. JAMA 2021; 325:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotwal AA, Cenzer IS, Waite LJ, et al. The epidemiology of social isolation and loneliness among older adults during the last years of life. J Am Geriatr Soc 2021; 69:3081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu B. Social isolation and loneliness among older adults in the context of COVID-19: a global challenge. Glob Health Res Policy 2020; 5:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Social support and health-related quality of life among older adults--Missouri, 2000. MMWR Morb Mortal Wkly Rep 2005; 54:433.
          </a>
         </li>
         <li class="breakAll">
          Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care System, National Academies Press (US).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perissinotto CM, Stijacic Cenzer I, Covinsky KE. Loneliness in older persons: a predictor of functional decline and death. Arch Intern Med 2012; 172:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoogendijk EO, Smit AP, van Dam C, et al. Frailty Combined with Loneliness or Social Isolation: An Elevated Risk for Mortality in Later Life. J Am Geriatr Soc 2020; 68:2587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu B, Steptoe A, Chen Y. Social isolation, loneliness, and all-cause mortality: A cohort study of 35,254 Chinese older adults. J Am Geriatr Soc 2022; 70:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malhotra R, Tareque MI, Saito Y, et al. Loneliness and health expectancy among older adults: A longitudinal population-based study. J Am Geriatr Soc 2021; 69:3092.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt-Lunstad J, Smith TB, Baker M, et al. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci 2015; 10:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell VD, Kumar N, Galecki AT, et al. Bad company: Loneliness longitudinally predicts the symptom cluster of pain, fatigue, and depression in older adults. J Am Geriatr Soc 2022; 70:2225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotwal AA, Meier DE. A paradigm shift-Loneliness as a root cause of symptom distress among older adults. J Am Geriatr Soc 2022; 70:2201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotwal AA, Fuller SM, Myers JJ, et al. A peer intervention reduces loneliness and improves social well-being in low-income older adults: A mixed-methods study. J Am Geriatr Soc 2021; 69:3365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallo JJ, Rabins PV, Lyketsos CG, et al. Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc 1997; 45:570.
          </a>
         </li>
         <li class="breakAll">
          Depression Guidelines Panel. Depression in Primary Care: Volume 1, Detection and Diagnosis, Clinical Practice Guideline, No. 5. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, MD 1993.
         </li>
         <li class="breakAll">
          US Preventive Services Task Force. Guide to Clinical Preventive Services. Available at: www.ahrq.gov/clinic/uspstfix.htm (Accessed on December 19, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakajima GA, Wenger NS. Quality indicators for the care of depression in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl 2:S302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012; 366:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berry SD, Samelson EJ, Pencina MJ, et al. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. JAMA 2013; 310:1256.
          </a>
         </li>
         <li class="breakAll">
          US Preventive Services Task Force (USPSTF). Screening for Osteoporosis. Available at: www.ahrq.gov/clinic/uspstf/uspsoste.htm (Accessed on December 21, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2022; 327:2123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popelka MM, Cruickshanks KJ, Wiley TL, et al. Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc 1998; 46:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yueh B, Shekelle P. Quality indicators for the care of hearing loss in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl 2:S335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Genther DJ, Frick KD, Chen D, et al. Association of hearing loss with hospitalization and burden of disease in older adults. JAMA 2013; 309:2322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin FR, Yaffe K, Xia J, et al. Hearing loss and cognitive decline in older adults. JAMA Intern Med 2013; 173:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325:1196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pirozzo S, Papinczak T, Glasziou P. Whispered voice test for screening for hearing impairment in adults and children: systematic review. BMJ 2003; 327:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou R, Dana T, Bougatsos C, et al. Screening adults aged 50 years or older for hearing loss: a review of the evidence for the U.S. preventive services task force. Ann Intern Med 2011; 154:347.
          </a>
         </li>
         <li class="breakAll">
          Clinical Preventive Services Self-Evaluation Module, Appendix a-1, American Board of Internal Medicine.
         </li>
         <li class="breakAll">
          Geriatrics Review Syllabus Supplement, 1993-1994 ed, Reuben DB, Yoshikawa TT, Besdine RW (Eds), American Geriatrics Society, New York 1993. p.172.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan DH. Impact of nutritional status on health outcomes of nursing home residents. J Am Geriatr Soc 1995; 43:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuben DB. Quality indicators for the care of undernutrition in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl 2:S438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med 2016; 176:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009; :CD000227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012; 367:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA 2020; 324:1855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mursu J, Robien K, Harnack LJ, et al. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med 2011; 171:1625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998; 46:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lifford KL, Curhan GC, Hu FB, et al. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc 2005; 53:1851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandeis GH, Baumann MM, Hossain M, et al. The prevalence of potentially remediable urinary incontinence in frail older people: a study using the Minimum Data Set. J Am Geriatr Soc 1997; 45:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts RO, Jacobsen SJ, Rhodes T, et al. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc 1998; 46:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steckenrider J. Sexual activity of older adults: let's talk about it. Lancet Healthy Longev 2023; 4:e96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Willlams CM. Using medications appropriately in older adults. Am Fam Physician 2002; 66:1917.
          </a>
         </li>
         <li class="breakAll">
          Essentials of Clinical Geriatrics, 4th ed., Kane R, Ouslander J, Abrass I (Eds), McGraw-Hill, New York 1999. p.379.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl 2:S373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019; 67:674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kramarow E, Chen LH, Hedegaard H, Warner M. Deaths from unintentional injury among adults aged 65 and over: United States, 2000-2013. NCHS Data Brief 2015; :199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner S, Arthur G, Lyons RA, et al. Modification of the home environment for the reduction of injuries. Cochrane Database Syst Rev 2011; :CD003600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang CC, Carr DB, Older Drivers Project. Older driver safety: a report from the older drivers project. J Am Geriatr Soc 2004; 52:143.
          </a>
         </li>
         <li class="breakAll">
          Physician's Guide to Assessing and Counseling Older Drivers. Available at: www.ama-assn.org/ama/pub/category/10791.html (Accessed on October 12, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reger MA, Welsh RK, Watson GS, et al. The relationship between neuropsychological functioning and driving ability in dementia: a meta-analysis. Neuropsychology 2004; 18:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubinsky RM, Stein AC, Lyons K. Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000; 54:2205.
          </a>
         </li>
         <li class="breakAll">
          Cubanski J, Koma W, Damico A, Neuman T. How many seniors live in poverty? Kaiser Family Foundation 2018. https://www.kff.org/report-section/how-many-seniors-live-in-poverty-issue-brief/ (Accessed on November 24, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lachs MS, Pillemer K. Elder abuse. Lancet 2004; 364:1263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dong X, Simon M, Mendes de Leon C, et al. Elder self-neglect and abuse and mortality risk in a community-dwelling population. JAMA 2009; 302:517.
          </a>
         </li>
         <li class="breakAll">
          Aravanis S, Adelman R, Breckman R. Diagnostic and Treatment Guidelines on Elder Abuse and Neglect, American Medical Association, Chicago 1992.
         </li>
         <li class="breakAll">
          Centers for Medicare and Medicaid Services. Frequently asked questions about billing the physician fee schedule for advance care planning services. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/Downloads/FAQ-Advance-Care-Planning.pdf (Accessed on June 29, 2016).
         </li>
         <li class="breakAll">
          The ABCs of the Initial Pteventive Physical Examination (IPPE) (Accessed on November 19, 2017).
         </li>
         <li class="breakAll">
          Older Adults. US Department of Health and Human Services. Available at: https://health.gov/healthypeople/objectives-and-data/browse-objectives/older-adults (Accessed on October 23, 2021).
         </li>
         <li class="breakAll">
          Publication &amp; Tools. American Geriatrics Society. Available at: https://www.americangeriatrics.org/publications-tools (Accessed on October 23, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fulmer T, Mate KS, Berman A. The Age-Friendly Health System Imperative. J Am Geriatr Soc 2018; 66:22.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3017 Version 103.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://www.cdc.gov/aging/pdf/saha_2007.pdf" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America 2007. The Merck Company Foundation, Whitehouse Station, NJ 2007. Available at: http://www.cdc.gov/aging/pdf/saha_2007.pdf (Accessed on April 12, 2012).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2013. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf (Accessed on August 25, 2015).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17679703" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Geriatric conditions and disability: the Health and Retirement Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24322396" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Incorporating lag time to benefit into prevention decisions for older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18954844" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Preventive health care among older women: missed opportunities and poor targeting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16046654" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Delivery of preventive services to older adults by primary care physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20040557" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Medical care for the final years of life: "When you're 83, it's not going to be 20 years".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23881930" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Unhealthy behaviours and disability in older adults: three-City Dijon cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23881930" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Unhealthy behaviours and disability in older adults: three-City Dijon cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21045101" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Maximizing the potential of an aging population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31095087" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Physical Activity, Injurious Falls, and Physical Function in Aging: An Umbrella Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17671236" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7715058" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8617896" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Balance and strength training in older adults: intervention gains and Tai Chi maintenance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8617895" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention Techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16829774" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Efficacy of smoking cessation intervention among special populations: review of the literature from 2000 to 2005.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11067570" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Cigarette smoking among the elderly: disease consequences and the benefits of cessation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11067570" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cigarette smoking among the elderly: disease consequences and the benefits of cessation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/476401" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Effect of general practitioners' advice against smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22688992" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Smoking and all-cause mortality in older people: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22688992" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Smoking and all-cause mortality in older people: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Smoking cessation in the elderly
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Smoking cessation in the elderly
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24101531" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The prevalence of harmful and hazardous alcohol consumption in older U.S. adults: data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910565" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Quality indicators for screening and prevention in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910565" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Quality indicators for screening and prevention in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35471505" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31054846" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18836135" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18836135" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8159158" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Tetanus--Kansas, 1993.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29702631" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7239554" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Secondary response to boostering by purified aluminium-hydroxide-adsorbed tetanus anatoxin in aging and in aged adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8410405" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10968321" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8065407" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8065407" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8065407" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17392303" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Varicella-zoster vaccine for the prevention of herpes zoster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17392303" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Varicella-zoster vaccine for the prevention of herpes zoster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17392303" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Varicella-zoster vaccine for the prevention of herpes zoster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11386931" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Cancer screening in elderly patients: a framework for individualized decision making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19119555" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Cancer screening in the older patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20929471" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Screening in frail older people: an ounce of prevention or a pound of trouble?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25023249" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Cancer screening in older adults: What to do when we don't know
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27542429" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Cancer Screening in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32128689" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Scripts and Strategies for Discussing Stopping Cancer Screening with Adults&gt; 75 Years: a Qualitative Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32128689" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Scripts and Strategies for Discussing Stopping Cancer Screening with Adults&gt; 75 Years: a Qualitative Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8096941" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Breast cancer screening with mammography: overview of Swedish randomised trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11684218" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Cochrane review on screening for breast cancer with mammography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24691608" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A systematic assessment of benefits and risks to guide breast cancer screening decisions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24691609" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Screening mammography in older women: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24378846" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Development and evaluation of a decision aid on mammography screening for women 75 years and older.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23385442" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23385442" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11890589" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Advancing age and cervical cancer screening and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1967429" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Screening for cancer of the cervix in elderly women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9933195" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Withdrawing low risk women from cervical screening programmes: mathematical modelling study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1503355" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Cost effectiveness of cervical cancer screening for the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8462016" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pap smears, elderly women, and Medicare.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7122435" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Cancer preventive screening behavior among elderly women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1992718" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Clinical implications of screening for cervical cancer under Medicare. The natural history of cervical cancer in the elderly: what do we know? What do we need to know?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7884116" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Predictors of Pap smear screening in socioeconomically disadvantaged elderly women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7884116" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Predictors of Pap smear screening in socioeconomically disadvantaged elderly women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21714641" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Reduced lung-cancer mortality with low-dose computed tomographic screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8548526" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Cancer statistics, 1996.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8548526" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cancer statistics, 1996.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17608248" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12457784" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25226479" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Evaluation and treatment of older patients with hypercholesterolemia: a clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12443589" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17502630" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : A sustained mortality benefit from screening for abdominal aortic aneurysm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7648155" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26501513" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2971088" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : A longitudinal study of functional change and mortality in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1466363" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Value of functional status as a predictor of mortality: results of a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21205966" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Gait speed and survival in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15381343" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11907291" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : A controlled trial of inpatient and outpatient geriatric evaluation and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26622001" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Recommendations on screening for cognitive impairment in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26622001" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Recommendations on screening for cognitive impairment in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26622001" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Recommendations on screening for cognitive impairment in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24491321" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Development and validation of a brief dementia screening indicator for primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23265826" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24663815" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24145578" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17551132" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Does this patient have dementia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15559753" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33560310" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Social Isolation and Loneliness: Imperatives for Health Care in a Post-COVID World.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34247388" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : The epidemiology of social isolation and loneliness among older adults during the last years of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32514427" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Social isolation and loneliness among older adults in the context of COVID-19: a global challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15889012" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Social support and health-related quality of life among older adults--Missouri, 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15889012" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Social support and health-related quality of life among older adults--Missouri, 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22710744" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Loneliness in older persons: a predictor of functional decline and death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32700319" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Frailty Combined with Loneliness or Social Isolation: An Elevated Risk for Mortality in Later Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35229887" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Social isolation, loneliness, and all-cause mortality: A cohort study of 35,254 Chinese older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34231876" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Loneliness and health expectancy among older adults: A longitudinal population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25910392" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Loneliness and social isolation as risk factors for mortality: a meta-analytic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35415848" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Bad company: Loneliness longitudinally predicts the symptom cluster of pain, fatigue, and depression in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35607720" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : A paradigm shift-Loneliness as a root cause of symptom distress among older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34449870" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : A peer intervention reduces loneliness and improves social well-being in low-income older adults: A mixed-methods study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9158577" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Depression without sadness: functional outcomes of nondysphoric depression in later life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9158577" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Depression without sadness: functional outcomes of nondysphoric depression in later life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9158577" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Depression without sadness: functional outcomes of nondysphoric depression in later life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910551" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Quality indicators for the care of depression in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12609940" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22256806" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Bone-density testing interval and transition to osteoporosis in older women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24065012" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24065012" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35608838" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9736098" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910555" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Quality indicators for the care of hearing loss in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23757078" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Association of hearing loss with hospitalization and burden of disease in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23337978" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Hearing loss and cognitive decline in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33755083" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Screening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14576249" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Whispered voice test for screening for hearing impairment in adults and children: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21357912" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Screening adults aged 50 years or older for hearing loss: a review of the evidence for the U.S. preventive services task force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21357912" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Screening adults aged 50 years or older for hearing loss: a review of the evidence for the U.S. preventive services task force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21357912" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Screening adults aged 50 years or older for hearing loss: a review of the evidence for the U.S. preventive services task force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7836649" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Impact of nutritional status on health outcomes of nursing home residents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910568" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Quality indicators for the care of undernutrition in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17634462" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Vitamin D deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26747333" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16481635" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Calcium plus vitamin D supplementation and the risk of fractures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19370554" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22762317" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : A pooled analysis of vitamin D dose requirements for fracture prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33170239" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21987192" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Dietary supplements and mortality rate in older women: the Iowa Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9560071" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16274364" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Type 2 diabetes mellitus and risk of developing urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9033516" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : The prevalence of potentially remediable urinary incontinence in frail older people: a study using the Minimum Data Set.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9560070" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36739874" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Sexual activity of older adults: let's talk about it.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12469968" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Using medications appropriately in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12469968" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Using medications appropriately in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17910560" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Quality indicators for medication use in vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30693946" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : American Geriatrics Society 2019 Updated AGS Beers Criteria®for Potentially Inappropriate Medication Use in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25973998" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Deaths from unintentional injury among adults aged 65 and over: United States, 2000-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21328262" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Modification of the home environment for the reduction of injuries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14687330" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Older driver safety: a report from the older drivers project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14687330" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Older driver safety: a report from the older drivers project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14744191" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : The relationship between neuropsychological functioning and driving ability in dementia: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10881240" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10881240" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15464188" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Elder abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19654386" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Elder self-neglect and abuse and mortality risk in a community-dwelling population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28876455" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : The Age-Friendly Health System Imperative.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
